Aspen Grove Capital, LLC Astrazeneca PLC Transaction History
Aspen Grove Capital, LLC
- $452 Billion
- Q3 2024
A detailed history of Aspen Grove Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aspen Grove Capital, LLC holds 6,277 shares of AZN stock, worth $396,894. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,277
Previous 5,987
4.84%
Holding current value
$396,894
Previous $467 Million
4.74%
% of portfolio
0.11%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.98 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.65 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.36 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...